tenk.fyi

SAB Biotherapeutics, Inc.

SABSNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$0

100.0% YoY

Net Income

$13.3M

138.9% YoY

EPS

$-0.79

78.5% YoY

Cash

$10.5M

18.0% YoY

FY 2025 · As of 2025-12-31